Skip to main content

Advertisement

SpringerLink
Log in

The role of integrated 18F-FDG PET/CT in identification of ectopic ACTH secretion tumors

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

The role of 18F-Flurodeoxyglucose positron emission tomography (18F-FDG PET) scan in localization of ectopic Cushing’s syndrome (EAS) tumor is still controversial. Here, we report on the use of integrated 18F-FDG PET and computed tomography (18F-FDG PET/CT) in localization of EAS tumors in patients with ectopic Cushing’s syndrome. Five patients, three men and two women, were reported, whose endocrine investigations and negative pituitary imaging were suggestive of ectopic ACTH secretion. 18F-FDG PET/CT was performed to identify the source of ACTH secretion. Then the patients were suggested to perform pathologic examination. It turned out that all of these five patients have abnormal markedly intense FDG uptake lesions on 18F-FDG PET/CT images. Four of them underwent lesion resection, whose plasma ACTH and serum cortisol levels returned to normal after the surgery. Also, they were at last remission from all the symptoms. Pathologic results showed one thymic carcinoid, one pulmonary carcinoid, one thymoma, and one pulmonary carcinoid with upper mediastinum carcinoid. Unfortunately, one patient died due to severe infection and electrolyte disorders. 18F-FDG PET/CT technology integrates PET and CT imaging in one device so as to increase the accuracy of tumor localization and further improve the prognosis of the patients by curative resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. A.M. Isidori, G.A. Kaltsas, S. Mohammed, D.G. Morris, P. Jenkins, S.L. Chew et al., Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing’s syndrome. J. Clin. Endocrinol. Metab. 88, 5299–5306 (2003)

    Article  CAS  PubMed  Google Scholar 

  2. A.M. Isidori, G.A. Kaltsas, C. Pozza, V. Frajese, J. Newell-Price, R.H. Reznek et al., The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management and long-term follow-up. J. Clin. Endocrinol. Metab. 91, 371–377 (2006)

    Article  CAS  PubMed  Google Scholar 

  3. A.M. Isidori, A. Lenzi, Ectopic ACTH syndrome. Arq. Bras. Endocrinol. Metabol. 51(8), 1217–1225 (2007)

    PubMed  Google Scholar 

  4. J.P. Aniszewski, W.F. Young Jr, G.B. Thompson, C.S. Grant, J.A. van Heerden, Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J. Surg. 25(7), 934–940 (2001)

    Article  CAS  PubMed  Google Scholar 

  5. I. Ilias, D.J. Torpy, K. Pacak, N. Mullen, R.A. Wesley, L.K. Nieman, Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J. Clin. Endocrinol. Metab. 90, 4955–4962 (2005)

    Article  CAS  PubMed  Google Scholar 

  6. B.M. Biller, A.B. Grossman, P.M. Stewart, S. Melmed, X. Bertagna, J. Bertherat et al., Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 93(7), 2454–2462 (2008)

    Article  CAS  PubMed  Google Scholar 

  7. A.M. Groves, H.K. Mohan, E.A. Wegner, S.F. Ham, S.B. Bingham, S.E. Clarke, PET with FDG to show thymic carcinoid. Am. J. Roentgenol. 82, 511–513 (2004)

    Google Scholar 

  8. E. Gomard-Mennesson, P. Sève, E. De La Roche, S. Collardeau-Frachon, C. Lombard-Bohas, C. Broussolle, Thymic carcinoid tumor revealed by a Cushing’s syndrome: usefulness of positron emission tomography. Rev. Med. Interne 29(9), 751–753 (2008). (Epub 2008 Mar 4)

    Article  CAS  PubMed  Google Scholar 

  9. H. Biering, M. Pirlich, J. Bauditz, D. Sandrock, H. Lochs, H. Gerl, PET scan in occult ectopic ACTH syndrome: a useful tool? Clin. Endocrinol. 59, 404–405 (2003)

    Article  CAS  Google Scholar 

  10. A. Markou, P. Manning, B. Kaya, S.N. Datta, J.B. Bomanji, G.S. Conway, [18F] Fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing’s syndrome. Eur. J. Endocrinol. 152, 521–525 (2005)

    Article  CAS  PubMed  Google Scholar 

  11. J. Kumar, M. Spring, P.V. Carroll, S.F. Barrington, J.K. Powrie, 18Flurodeoxyglucose positron emission tomography in the localization of ectopic ACTH-secreting neuroendocrine tumours. Clin. Endocrinol. 64, 371–374 (2006)

    CAS  Google Scholar 

  12. A.B. Moraes, G.F. Taboada, M.P. Carneiro, L.V. Neto, L.E. Wildemberg, K. Madi et al., Utility of [18F] fluoro-2-deoxy-D-glucose positron emission tomography in the localization of ectopic ACTH-secreting tumors. Pituitary, 2008 May 6. (Epub ahead of print)

  13. S. Adams, R. Baum, T. Rink, P.M. Schumm-Dräger, K.H. Usadel, G. Hör, Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur. J. Nucl. Med. 25(1), 79–83 (1998)

    Article  CAS  PubMed  Google Scholar 

  14. J.J. Erasmus, H.P. McAdams, E.F. Patz Jr, R.E. Coleman, V. Ahuja, P.C. Goodman, Evaluation of primary pulmonary carcinoid tumors using FDG PET. Am. J. Roentgenol. 170, 1369–1373 (1998)

    CAS  Google Scholar 

  15. C. Le Rest, J.B. Bomanji, D.C. Costa, C.E. Townsend, D. Visvikis, P.J. Ell, Functional imaging of malignant paragangliomas and carcinoid tumours. Eur. J. Nucl. Med. 28, 478–482 (2001)

    Article  PubMed  Google Scholar 

  16. V.T. de Montpreville, P. Macchiarini, E. Dulmet, Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of fourteen cases. J. Thorac. Cardiovasc. Surg. 111, 134–141 (1996)

    Article  PubMed  Google Scholar 

  17. S. Adams, R.P. Baum, A. Hertel, P.M. Schumm-Drager, K.H. Usadel, G. Hor, Metabolic (PET) and receptor (SPET) imaging of well- and less well-differentiated tumours: comparison with the expression of the Ki-67 antigen. Nucl. Med. Commun. 19, 641–647 (1998)

    Article  CAS  PubMed  Google Scholar 

  18. C. Pasquali, D. Rubello, C. Sperti, P. Gasparoni, G. Liessi, F. Chierichetti, G. Ferlin, S. Pedrazzoli, Neuroendocrine tumor imaging: can 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior? World J. Surg. 22, 588–592 (1998)

    Article  CAS  PubMed  Google Scholar 

  19. M. Okumura, M. Ohta, H. Tateyama et al., The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94(3), 624–632 (2002)

    Article  PubMed  Google Scholar 

  20. K. Pacak, I. Ilias, C.C. Chen, J.A. Carrasquillo, M. Whatley, L.K. Nieman, The role of 18F flourodeoxyglucose positron emission tomography and 111In–diethylenetriaminepentaacetate-D-phe-pentreotide scintigraphy in the localisation of ectopic adrenocorticotropin-secreting tumours causing Cushing’s syndrome. J. Clin. Endocrinol. Metab. 89, 2214–2221 (2004)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This work was supported by Shanghai Leading Academic Discipline Project S30203.

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, No.197, Rui Jin Er Road, Shanghai, 200025, People’s Republic of China

    Haoping Xu, Min Zhang, Ge Zhai, Miao Zhang & Biao Li

  2. Shanghai Institute of Endocrinology and Metabolism, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

    Guang Ning

Authors
  1. Haoping Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Min Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ge Zhai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Miao Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guang Ning
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Biao Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Biao Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, H., Zhang, M., Zhai, G. et al. The role of integrated 18F-FDG PET/CT in identification of ectopic ACTH secretion tumors. Endocr 36, 385–391 (2009). https://doi.org/10.1007/s12020-009-9247-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-009-9247-2

Keywords

Search

Navigation